
Summit Therapeutics Inc.
Summit Therapeutics Inc. (SMMT)
WebsitePrice
Market cap
Next catalystExpected Q4 2026Ivonescimab + gemcitabine/cisplatin — EA2251 · Trial initiationCompany source ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Representative pipeline applications
Clinical
Upcoming clinical milestones
Other pipelines
Partner / License out
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved